Figure S2. Enhancing the wound healing assay (2D migration assay) and the Boyden chamber assay (3D migration assay) with a double fluorescence labelling allows for the visualization of the position of the nucleus relative to the cytoplasm in migrating cells. U87MG (A) and SKOV-3 (B) were subjected to migration in a wound healing assay. MDA-MB-231 (C) and LNCaP (D) were subjected to migration in a Boyden chamber assay. Arrows, nucleus at the back of the cell; arrowheads, nuclei at the front of the cell. White lines in A and B mark the border of the wound. Scale bars = 75 μm. (TIF 6039 kb
Figure S1. Loss of SEMA5A increases migration ability in PC cells. A. Scratch assay showing higher c...
HN1 knockdown inhibits the self-renewal of BCSCs and invasion and migration of breast cancer cells. ...
Chemotherapeutic drugs increase CD26 protein expression on live cells but do not alter immunoreactiv...
Figure S1. Alterations in cellular morphology caused by cytostatic concentrations of MF in cancer ce...
Figure S4. Cells closer to the wound express little to no pHH3 when compared with cells located fart...
Figure S3. Observing relative distribution of F-actin within nucleus and cytoplasm. Images depict mi...
Figure S1. Wound healing assay of primary HCC cells. Wound healing assay. (A) A wound was introduced...
Cells treated with LPS in the absence of M2-CM did not exhibit increased migration. (A) Cell migrati...
The modified Boyden chamber assay. A) Schematic diagram (sagittal section) of one well of the modifi...
Figure S3. The GPER antagonist G-15 reduces the migration of MDA-MB 231 TNBC cells induced by E2 and...
(a) Representative flow cytometric analysis on immature and mature DCs. The purple histograms repres...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
Anticancer agents decrease CXCR4+ cells and increase cell-surface expression of CD26 in the HT-29 ce...
Figure S1. Cellular viability assays of co-cultured SUM149 (A) and SUM159 (B) cells on the bottom ch...
Figure S1. Trans-endothelial migration assay. (A) Schematic representation of the trans-endothelial ...
Figure S1. Loss of SEMA5A increases migration ability in PC cells. A. Scratch assay showing higher c...
HN1 knockdown inhibits the self-renewal of BCSCs and invasion and migration of breast cancer cells. ...
Chemotherapeutic drugs increase CD26 protein expression on live cells but do not alter immunoreactiv...
Figure S1. Alterations in cellular morphology caused by cytostatic concentrations of MF in cancer ce...
Figure S4. Cells closer to the wound express little to no pHH3 when compared with cells located fart...
Figure S3. Observing relative distribution of F-actin within nucleus and cytoplasm. Images depict mi...
Figure S1. Wound healing assay of primary HCC cells. Wound healing assay. (A) A wound was introduced...
Cells treated with LPS in the absence of M2-CM did not exhibit increased migration. (A) Cell migrati...
The modified Boyden chamber assay. A) Schematic diagram (sagittal section) of one well of the modifi...
Figure S3. The GPER antagonist G-15 reduces the migration of MDA-MB 231 TNBC cells induced by E2 and...
(a) Representative flow cytometric analysis on immature and mature DCs. The purple histograms repres...
Figure S1. a Cancer-associated fibroblasts (CAFs) culture-conditioned media used with MKN-45 and MKN...
Anticancer agents decrease CXCR4+ cells and increase cell-surface expression of CD26 in the HT-29 ce...
Figure S1. Cellular viability assays of co-cultured SUM149 (A) and SUM159 (B) cells on the bottom ch...
Figure S1. Trans-endothelial migration assay. (A) Schematic representation of the trans-endothelial ...
Figure S1. Loss of SEMA5A increases migration ability in PC cells. A. Scratch assay showing higher c...
HN1 knockdown inhibits the self-renewal of BCSCs and invasion and migration of breast cancer cells. ...
Chemotherapeutic drugs increase CD26 protein expression on live cells but do not alter immunoreactiv...